Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Outcomes ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Secondary ...

Pulsed field ablation did not have superior efficacy to radiofrequency ablation in patients with drug-resistant paroxysmal (intermittent) atrial fibrillation, according to results from a late-breaking ...

EHRA late-breaking data: Results highlight efficacy, safety, and durability of the novel PFA catheter that is fully integrated with Affera™ Mapping and Ablation System DUBLIN and BERLIN, April 8, 2024 ...

Please provide your email address to receive an email when new articles are posted on . The FDA approved a navigation-enabled ablation catheter for the treatment of ...

Dear Dr. Roach: I am an 88-year-old female in relatively good health. A year and a half ago, I did experience atrial fibrilliation and had two cardioversions. (The first was good for a year; the ...

Pulsed field ablation (PFA) is as effective and safe as conventional thermal ablation for the treatment of paroxysmal atrial fibrillation (AF), according to late breaking research presented in a Hot ...

Atrial fibrillation, or A-fib, is the most common type of arrhythmia, affecting at least 2.7 million people in the United States. This number is expected to grow to more than 12 million by 2030, which ...

SANTA CLARA, Calif., Oct. 4, 2018 /PRNewswire/ -- EPIX Therapeutics, Inc., a medical device company that designs and manufactures a catheter-based system for the treatment of patients with atrial ...

DEAR DR. ROACH: I am an 88-year-old female in relatively good health. A year and a half ago, I did experience atrial fibrilliation and had two cardioversions. (The first was good for a year; the ...